CWM
BBIO icon

CIBC World Markets’s BridgeBio Pharma BBIO Stock Holding History

CIBC World Markets’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$803K Buy
+10,500
New +$689K ﹤0.01% 763
2025
Q2 		$832K Sell
19,268
-11,924
-38% -$434K 0.01% 699
2025
Q1 		$1.08M Buy
31,192
+18,037
+137% +$608K 0.01% 666
2024
Q4 		$361K Buy
+13,155
New +$340K ﹤0.01% 859

Other funds holding BBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC World Markets's BBIO Position: Q4 2025 in Review

CIBC World Markets opened a new position in BridgeBio Pharma (BBIO) in Q4 2025: 10,500 shares worth $803K. The stake represents ﹤0.01% of the portfolio and ranks #763 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in BBIO as recently as Q2 2025.

CIBC World Markets first reported a position in BBIO in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.08M in Q1 2025. 433 funds tracked by Wall St. Rank hold BBIO as of Q4 2025.

  • CIBC World Markets held 10,500 shares of BridgeBio Pharma worth $803K as of Q4 2025.
  • BridgeBio Pharma was a new CIBC World Markets position in Q4 2025.
  • BridgeBio Pharma made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #763 holding.
  • CIBC World Markets first reported a position in BridgeBio Pharma in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's BridgeBio Pharma position peaked at $1.08M in Q1 2025.
  • 433 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.